Bioanalysis Zone

Global outsourcing

0
“…pharmaceutical companies’ investment on outsourcing will continue to grow in the next 3–5 years as a means to control in-house R&D expenses, increase capacities and improve core expertise. The outsourcing strategies for pharmaceutical companies will be collaborative and partnered with contract research organizations.”

Drug development has become a tremendous challenge for most pharmaceutical companies today. Investment of US$1 billion and 10 years are very common in order to launch any new drug, not to mention that it is also common for a promising candidate to fail to become a manufacturable and marketable therapy after many years of development [1].

To view restricted content, please:
Share:

Leave A Comment